FIELD: medicine; neonatology; pediatrics; anesthesiology and resuscitation, obstetrics and gynecology.
SUBSTANCE: invention can be used to predict the development of early neonatal sepsis in newborns whose mothers suffered from COVID-19 during pregnancy. A comprehensive assessment is performed of the anamnestic data of the mother: premature rupture of amniotic fluid, and of the newborn: the sex of the child, suspected or confirmed diagnosis of early neonatal infection, the presence of respiratory distress syndrome, as well as the results of laboratory tests of the child: hyperbilirubinemia on the first day. The diagnostic index (DI) is calculated by the following formula: DI = 1,578 X1 – 1,704 X2 – 2,591 X3 + 4,116 X4 + 2,903 X5 – 1,1, where: X1 is respiratory distress syndrome: in case of presence of respiratory distress syndrome X1 is equal to 1, in case of absence of respiratory distress syndrome X1 is equal to 0; X2 is gender of the child: in case of male X2 is equal to 1, in case of female X2 is equal to 0; X3 is hyperbilirubinemia: in case of presence of hyperbilirubinemia, X3 is equal to 1, in case of absence of hyperbilirubinemia X3 is equal to 0; X4 is suspected or confirmed diagnosis of early neonatal infection P 39. ICD-10: if present, X4 is equal to 1, if absent, X4 is equal to 0; X5 is premature rupture of amniotic fluid: if present, X5 is equal to 1, if absent, X5 is equal to 0. When DI is more than 0, a high risk of sepsis in newborns in the neonatal period is predicted. When DI is less than 0, no signs of neonatal sepsis are predicted.
EFFECT: method provides the ability to predict the development of neonatal sepsis in newborns using available methods and optimize management tactics for this category of children through a comprehensive assessment of the anamnestic data of the mother and newborn and the results of laboratory tests of the child based on mathematical processing of the research results.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING MORTALITY IN NEWBORNS WHOSE MOTHERS HAD COVID-19 DURING PREGNANCY | 2023 |
|
RU2800892C1 |
| METHOD FOR PREDICTION OF VACCINATION OF NEWBORNS FROM HIGH-RISK GROUPS AGAINST TUBERCULOSIS IN MATERNITY HOME | 2017 |
|
RU2645109C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF HYPERBILIRUBINEMIA IN FULL-TERM NEWBORNS BORN BY THE CESAREAN SECTION OPERATION METHOD | 2019 |
|
RU2711107C1 |
| EARLY DIAGNOSTIC TECHNIQUE FOR BACTERIAL PNEUMONIA COMBINED WITH RESPIRATORY DISTRESS SYNDROME OF PREMATURE NEWBORN | 2008 |
|
RU2382362C1 |
| METHOD FOR PREDICTING RISK OF ISCHEMIC DAMAGE TO CENTRAL NERVOUS SYSTEM OF MODERATE AND SEVERE SEVERITY IN FULL-TERM NEWBORNS BORN BY CAESAREAN SECTION | 2020 |
|
RU2753820C1 |
| METHOD FOR PREDICTING THE RISK OF INTESTINAL COLONIZATION BY KLEBSIELLA PNEUMONIAE IN PRETERM INFANTS IN THE NEONATAL PERIOD | 2022 |
|
RU2793050C1 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF INTRAVENTRICULAR HEMORRHAGES IN PREMATURE NEWBORNS | 2020 |
|
RU2741727C1 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF ARTERIAL AND VENOUS THROMBOSIS IN NEWBORNS | 2023 |
|
RU2818815C1 |
| METHOD FOR PREDICTION OF INTRAVENTRICULAR HEMORRHAGES IN PREMATURE NEWBORNS | 2020 |
|
RU2741722C1 |
| METHOD FOR PREDICTING SEVERE RESPIRATORY FAILURE IN NEWBORNS BORN TO MOTHERS WITH PREECLAMPSIA | 2020 |
|
RU2751287C1 |
